Cansartan-Mepha plus 32/25, Tabletten - 98 Tablette(n) Swissmedic Key 61215012 Registration Holder Mepha Pharma AG Name Cansartan-Mepha plus 32/25, Tabletten Date of registration 24.01.2011 Original/Generic Generic Introduction of Sequence 05.09.2014 ATC-Classification Candesartan and Diuretics (C09DA06) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 02.07.20. Show package size 98 Tablette(n) Index Therapeuticus (Swissmedic) 02.07.20. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 32.37 Limitation No Deductible 10 % Consumer price 51.75 Feedback FB GTIN 7680612150121 Medication Code Synthetika Pharmacode 6134204 Disponibility
Composition candesartanum cilexetilum 32.00 mg, hydrochlorothiazidum 25.00 mg, maydis amylum, lactosum monohydricum 218.60 mg, triethylis citras, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium 0.86 mg, magnesii stearas, pro compresso. Packungsbestandteile Galenic Form Tablets Active Agent Dose Candesartanum Cilexetil 32 mg Hydrochlorothiazide 25 mg
BAG: Active Agent Dose Candesartanum Cilexetil 32 mg Hydrochlorothiazide 25 mg
Inactive agents Dose Carmellosum Natricum Conexum Hydroxypropylcellulosum Lactose Monohydrate 218.6 mg Magnesii Stearas Maydis Amylum Pro Compresso Triethylis Citras
Source Data was imported : 12.05.2021
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
